PhenomeX Stock

PhenomeX Employees 2024

PhenomeX Employees

230

Ticker

CELL

ISIN

US0843101017

WKN

A2P9RR

In 2024, PhenomeX employed 230 people, a 0% change from the 230 number of employees in the previous year.

PhenomeX Aktienanalyse

What does PhenomeX do?

The company Berkeley Lights Inc. (BLI) is a biotech startup that was founded in 2011 by Eric Hobbs and Igor Khandros in California. They both had experience in the semiconductor electronics field and decided to utilize their skills to develop a new technology that allows researchers to quickly and efficiently investigate cell-specific processes. The concept behind BLI is based on a novel technology called the "Beacon system." Cells are held on thousands of tiny microchips and can be selectively manipulated using beams of light. The Beacon system enables researchers to isolate, analyze, and select cells rapidly and efficiently, significantly speeding up and simplifying the research process. BLI's business model can be described as B2B, as the company sells its technology and services to other companies in the biotech industry. BLI has two different divisions in which it utilizes its technology and expertise: the "OptoSelect" program and the "Beacon Discovery" program. BLI's OptoSelect program offers customers the ability to select precise and specific cell lines from a large array of cultures. BLI utilizes its Beacon technology to quickly and efficiently isolate and select cells, saving valuable time and resources for researchers. These cell lines can then be used in the development of drugs and therapies, increasing the chances of successful market introduction. BLI's Beacon Discovery program is focused on accelerating the discovery process of new drugs and therapies. BLI works closely with its customers to expedite the drug development process. By using the Beacon technology, it is possible to identify and test potential drug candidates more quickly, significantly reducing the development time. BLI also offers a range of products based on the Beacon technology. These include devices such as the Lightning™ Digital Array, a system for multi-omics analysis of gene expression, immune response, and cell cycle; the Beacon® Controller, a system for controlling the Beacon® microchip platform; and the Beacon® Pak for consumables. Since its founding, BLI has conducted multiple funding rounds and raised over $180 million for the development of its technology and services. The company has established strong partnerships with leading companies in the biotech industry and collaborates closely with researchers and universities to advance its technology. Overall, BLI has established itself as a leading provider of biotech technologies. Through the use of its Beacon technology, the company has accelerated and simplified the process of cell analysis and selection, speeding up the development of new drugs and therapies and increasing the chances of successful market introduction. With its state-of-the-art products and services, BLI is well-positioned to continue playing a significant role in the biotech industry in the future. PhenomeX ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining PhenomeX's Employee Base

PhenomeX's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding PhenomeX's operational capacity and future potential.

Year-to-Year Comparison

Assessing PhenomeX's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

PhenomeX's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in PhenomeX’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about PhenomeX stock

How many employees does PhenomeX have this year?

PhenomeX has 230 undefined employees this year.

How many employees did PhenomeX have compared to the previous year?

Compared to the previous year, PhenomeX had 0% more employees.

What impact did the number of employees have on the company PhenomeX?

The number of employees has a direct impact on the efficiency and productivity of PhenomeX. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of PhenomeX?

The number of employees can also have an impact on investors of PhenomeX, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of PhenomeX affect the company?

An increase in equity of PhenomeX can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in PhenomeX's equity affect the company?

A reduction in equity of PhenomeX can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of PhenomeX?

Some factors that can influence the equity of PhenomeX include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of PhenomeX so important for investors?

The equity of PhenomeX is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at PhenomeX influence the company?

The number of employees at PhenomeX can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at PhenomeX evolved in recent years?

In recent years, the number of employees at PhenomeX has changed by 0.

How many employees does PhenomeX currently have?

PhenomeX currently has 230 undefined employees.

Why is the number of employees important for investors of PhenomeX?

The number of employees is important for investors of PhenomeX as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can PhenomeX take to change the number of employees?

To change the number of employees, PhenomeX can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does PhenomeX pay?

Over the past 12 months, PhenomeX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PhenomeX is expected to pay a dividend of 0 USD.

What is the dividend yield of PhenomeX?

The current dividend yield of PhenomeX is .

When does PhenomeX pay dividends?

PhenomeX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PhenomeX?

PhenomeX paid dividends every year for the past 0 years.

What is the dividend of PhenomeX?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PhenomeX located?

PhenomeX is assigned to the 'Health' sector.

Wann musste ich die Aktien von PhenomeX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PhenomeX from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did PhenomeX pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of PhenomeX in the year 2023?

In the year 2023, PhenomeX distributed 0 USD as dividends.

In which currency does PhenomeX pay out the dividend?

The dividends of PhenomeX are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PhenomeX

Our stock analysis for PhenomeX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PhenomeX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.